Production of Human Glutathione S-Transferase Antibodies

Award Information
Agency:
Department of Health and Human Services
Amount:
$499,992.00
Program:
SBIR
Contract:
N/A
Solitcitation Year:
N/A
Solicitation Number:
N/A
Branch:
N/A
Award Year:
1993
Phase:
Phase I
Agency Tracking Number:
22217
Solicitation Topic Code:
N/A
Small Business Information
Anatrace, Inc.
1280 Dussel Drive, Maumee, OH, 43537
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 David E. Albert
 (419) 891-3030
Business Contact
Phone: () -
Research Institution
N/A
Abstract
Glutathione S-transferases (GSTs) are a complex multigene family of isozymes considered by many to be the single most important class of enzymes involved in the detoxication of endogenous and xenobiotic electrophilic substances including anticancer drugs. Some of these isozymes are polymorphic and can influence DNA adduct formation. Studying polymorphism of GSTs can yield useful information as to individual and tissue responses to toxic or carcinogenic chemicals. Specific antibodies to GST isozymes would allow investigators to study polymorphism and determine tissue specific levels of each enzyme even when enzymatically inactive because of the presence of inhibitors. Many of these antibodies are unavailable to laboratories involved in drug metabolism research. Therefore, the goal of Phase I is to produce specific antibodies to the isozymes of GST and to make them commercially available to the research community. This will be accomplished by extracting, purifying, and characterizing each isozyme followed by the production of murine polyclonal antibodies to each GST isozyme. The Phase II goals will be to establish viable antibody secreting hybridomas for each isozyme to insure a constant supply of highly specific monoclonal antibodies.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government